Ionis Pharmaceuticals, Inc.
COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN

Last updated:

Abstract:

Disclosed herein are compounds, compositions and methods for modulating the expression of huntingtin in a cell, tissue or animal. Further provided are methods of slowing or preventing Huntington's Disease (HD) progression using an antisense compound targeted to huntingtin. Additionally provided are methods of delaying or preventing the onset of Huntington's Disease (HD) in an individual susceptible to Huntington's Disease (HD). Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders.

Status:
Application
Type:

Utility

Filling date:

21 Jun 2021

Issue date:

10 Feb 2022